| chloratranol | F3 | strong | LLNA EC3 = 0.4%, pEC3 = 2.67 | (1) low Gly-pNA imine stability
(log K < 2, Table 1) | 
| (2) lowest imine
decomposition rates (k–1pseudo < 0.005 min–1, Table 1) | 
| (3) cross-linking
of protein structures (Scheme 8) | 
| human potency class
1 | (4) adduct stabilization through imine-enaminone tautomerisation11 | 
| (5) high lysine reactivity
at pH 7.511 (Table 2) | 
| (6) high cysteine-SH
reactivity39 | 
| atranol | F2 | strong | LLNA EC3 = 0.6%, pEC3 = 2.40 | (1) low Gly-pNA
imine stability (log K < 2, Table 1) | 
| (2)
lowest imine decomposition rates (k–1pseudo < 0.004 min–1, Table 1) | 
| (3) cross-linking of protein structures (Scheme 8, Natsch & Emter 201732) | 
| human potency class 1 | (4) adduct
stabilization through imine-enaminone tautomerization11 | 
| (5) high lysine reactivity at
pH 7.511 (Table 2) | 
| (6) high cysteine-SH
reactivity39 | 
| 2-bromo-5-hydroxy benzaldehyde | E4 | moderate | LLNA EC3 = 2.6%, pEC3 = 1.89 | (1) medium Gly-pNA imine stability (log K > 2, Table 1) | 
| (2) no lysine reactivity at pH 7.511 (Table 2) | 
| (3) SNAr-type adduct formation
with cysteine-SH
(Scheme 10) | 
| 4-chlorobenzaldehyde | D2 | weak/non | LLNA EC3 > 10%, pEC3 < 1.15 | (1) low Gly-pNA imine stability (log K < 2, Table 1) | 
| (2) moderate lysine reactivity
at pH 7.511 (Table 2) | 
| 4-isopropyl
benzaldehyde | B1 | weak/non | LLNA EC3 > 10%, pEC3 <1.17 | (1) very low Gly-pNA
imine stability (log K < 1, Table 1) | 
| (2)
low lysine reactivity at pH 7.511 (Table 2) | 
| 4-methyl benzaldehyde | A4 | weak/non | LLNA EC3 > 10% (0.69%) | (1) very low Gly-pNA
imine stability (log K < 1, Table 1) | 
| pEC3 <1.08 (2.24) | (2) very low lysine
reactivity at pH 7.511 (Table 2) | 
| 6-methoxy naphthalene carbaldehyde | F1 | weak/non | LLNA EC3 > 20%, pEC3 <1.17 | (1) low Gly-pNA imine stability (log K < 2, Table 1) | 
| (2) no lysine reactivity at pH
7.511 (Table 2) | 
| benzaldehyde | A1 | weak/non | LLNA EC3 > 25%, pEC3 < 0.63 | (1) low Gly-pNA imine stability (log K < 2, Table 1) | 
| human potency class 5 | (2) very low lysine reactivity at pH 7.511 (Table 2) | 
| LOEL 2760 μg/cm2 | 
| NOEL 590 μg/cm2 | 
| 4-hydroxy benzaldehyde | B4 | weak/non | LLNA EC3 > 25%, pEC3 < 0.69 | (1)
very low Gly-pNA imine stability (log K <
0, Table 1) | 
| (2) no lysine reactivity at pH 7.511 (Table 2) | 
| 4-methoxy benzaldehyde | C3 | weak/non | LLNA EC3 > 25%, pEC3 < 0.74 | (1) very low Gly-pNA imine stability (log K < 1, Table 1) | 
| LOEL 4724 μg/cm2 | (2) no lysine
reactivity at pH 7.511 (Table 2) | 
| NOEL-HRIPT 3543 μg/cm2 | 
| NOEL-HPT 6900 μg/cm2 | 
| 4-nitro benzaldehyde | D1 | weak/non | LLNA EC3 > 50%, pEC3 < 0.48 | (1) medium Gly-pNA imine stability (log K > 2, Table 1) | 
| (2) no lysine reactivity at pH
7.511 (Table 2) | 
| vanillin | D3 | weak/non | LLNA EC3 > 50%, pEC3 < 0.48 | (1) very low Gly-pNA imine stability (log K < 0, Table 1) | 
| human potency class 5 | (2) very low lysine reactivity at pH 7.511 (Table 2) | 
| NOEL 1181 μg/cm2 | 
| ethyl
vanillin | D4 | weak/non | LLNA EC3 > 50%, pEC3 < 0.52 | (1) very low Gly-pNA
imine stability (log K < 0, Table 1) | 
| (2)
very low lysine reactivity at pH 7.511 (Table 2) | 
| 3-chloro-4-methoxy benzaldehyde | E3 | weak/non | LLNA EC3 > 65%, pEC3 < 0.42 | (1) very low Gly-pNA imine stability (log K < 1, Table 1) | 
| (2) very low lysine reactivity
at pH 7.511 (Table 2) | 
| 2-hydroxy
benzaldehyde | B2 | -- | positive in human tests | (1) very low Gly-pNA adduct stability (log K < 1, Table 1) | 
| (2) moderate lysine reactivity at pH 7.511 (Table 2) |